Cencora, Inc.
CORCencora, Inc. (COR), formerly known as McKesson Corporation, is a global health care company that distributes pharmaceuticals, healthcare products, and medical supplies. It provides supply chain management, technology solutions, and healthcare services to hospitals, pharmacies, and other healthcare providers. The company plays a key role in ensuring the efficient flow of essential medical products across the healthcare industry.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| December 1, 2025 | $0.60 | 2025-11-14 | 2025-11-14 |
| September 3, 2025 | $0.55 | 2025-08-15 | 2025-08-15 |
| June 2, 2025 | $0.55 | 2025-05-16 | 2025-05-16 |
| March 3, 2025 | $0.55 | 2025-02-14 | 2025-02-14 |
| November 29, 2024 | $0.55 | 2024-11-15 | 2024-11-15 |
Dividends Summary
- Cencora, Inc. has issued 88 dividend payments over the past 21 years
- The most recent dividend was paid 7 days ago, on December 1, 2025
- The highest dividend payed out to investors during this period was $0.60 per share
- The average dividend paid during this period was $0.27 per share.
Company News
Iterum Therapeutics reports expanding market access for ORLYNVAH™, securing nearly 25% insurance coverage in the U.S. and signing a Medicare Part D rebate agreement with a top Pharmacy Benefit Manager, with potential coverage starting in Q1 2026.
Cencora reported strong Q3 financial results with sales increasing 8.7% to $80.66 billion, driven by growth in healthcare solutions and GLP-1 class product sales. The company raised its full-year adjusted EPS guidance and expects continued revenue growth.
Walgreens is facing cash flow issues, with negative operating cash flow in recent quarters and high current liabilities compared to current assets. The company has had to sell its stake in Cencora to raise cash, and its dividend cut earlier this year may not be enough to address the underlying problems.
Cencora (COR) shares declined on Jun 27, following an unfavorable ruling from the Supreme Court related to a previously settled litigation. Here we discuss the key factors that likely led to the decline.
